Association of transferrin C2 allele with late-onset Alzheimer's disease

Human Genetics

Volumn 101, Issue 2, 1997, Pages 126-129

  Namekata, Kazuhiko ^a   Imagawa, Masaki ^b   Terashi, Akiro ^c   Ohta, Shigeo ^c   Oyama, Fumitaka ^a   Ihara, Yasuo ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^c Institute of Gerontology   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; TRANSFERRIN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; GENE FREQUENCY; HOMOZYGOTE; HUMANS; MIDDLE AGED; TRANSFERRIN; VARIATION (GENETICS);

EID: 0031467468     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050600     Document Type: Article

References (26)

1. Bodovitz S, Falduto MT, Frail DE, Klein WL (1995) Iron levels modulate α-secretase cleavage of amyloid precursor protein. J Neurochem 64:307-315
2. Chung H, Roberts CT, Greenberg S, Rebeck GW, Christie R, Wallace R, Jacob HJ, Hyman BT (1996) Lack of association of trinucleotide repeat polymorphisms in the very-low-density lipoprotein receptor gene with Alzheimer's disease, Ann Neurol 39:800-803
3. Connor JR, Menzies SL, St. Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31:75-83
4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
5. Dai XY, Nanko S, Hattori M, Fukuda R, Nagata K, Isse K, Ueki A, Kazamatsuri H (1994) Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci Lett 175:74-76
6. Ehmann WD, Markesbery WR, Alauddin M, Hossain TIM, Brubaker EH (1986) Brain trace elements in Alzheimer's disease. Neurotoxicology 7:197-206
7. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak-Vance MA (1996) No genetic effect of alpha 1-antichymotrypsin in Alzheimer disease. Genomics 33:53-56
8. Hixon JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548
9. Imagawa M, Naruse S, Tsuji S, Fujioka A, Yamaguchi H (1992) Coenzyme Q10, iron, and vitamin B6 in genetically-confirmed Alzheimer's disease. Lancet 340:671
10. Kamboh MI, Ferrell RE (1987) Human transferrin polymorphism. Hum Hered 37:65-81
11. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995) APOE4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat Genet 10:486-488
12. Kennard ML, Feldman H, Yamada T, Jefferies WA (1996) Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nat Med 2:1230-1235
13. Kishi K, Ikehara Y, Yasuda T, Mizuta K, Sato W (1990) Transferrin polymorphism detected in human urine using isoelectric focusing followed by immunoblotting. Forensic Sci Int 45:225-230
14. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J Neurochem 61:1171-1174
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease. Neurology 34:939-944
16. Morgan K, Morgan L, Carpenter K, Lowe J, Lam L, Cave S, Xuereb J, Wischik C, Harrington C, Kalsheker NA (1997) Microsatellite polymorphism of the α1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum Genet 99:27-31
17. Nakanaga M, Yasuda T, Tenjo E, Nadano D, Fujiki N, Kishi K (1991) Transferrin polymorphisms in Japanese population: north-south cline in the distribution of the TF*C2 allele. Hum Biol 63:187-195
18. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541:163-166
19. Namekata K, Oyama F, Imagawa M, Ihara Y (1997) Human transferrin (Tf): a single mutation at codon 570 determines Tf C1 or Tf C2 variant. Hum Genet 100:457-458
20. Okuizumi K, Onodera O, Namba Y, Ikeda K, Yamamoto T, Seki K, Ueki A, Nanko S, Tanaka H, Takahashi H, Oyanagi K, Mizusawa H, Kanazawa I, Tsuji S (1995) Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet 11:207-209
21. Okuizumi K, Onodera O, Seki K, Tanaka H, Namba Y, Ikeda K, Saunders AM, Pericak-Vance MA, Roses AD, Tsuji S (1996) Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann Neurol 40:251-254
22. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K (1993) A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 163:166-168
23. Van Rensburg SJ, Carstens ME, Potocnik FC, Aucamp AK, Taljaard JJ (1993) Increased frequency of the transferrin C2 subtype in Alzheimer's disease. NeuroReport 4:1269-1271
24. Wennberg C, Kivela A, Holmgren PA (1996) Placental and germ cell alkaline phosphatase RFLPs and haplotypes associated with spontaneous abortion. Hum Hered 45:272-277
25. Wong CT, Saha N (1986) Effects of transferrin genetic phenotypes on total iron-binding capacity. Acta Haematol 75:215-218
26. Wragg M, Hutton M, Talbot C, Alzheimer's Disease Collaborative Group (1996) Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347:509-512